GlassScriptPhysician profile
Jorge Acosta
NPI 1396701207
$26,150.23
in general payments reported to CMS, 2019-2025
9 companies · $2,151 in 2025
The $2,151 reported for 2025 was more than what 83% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,898 · 2020: $1,198 · 2021: $112 · 2022: $11K · 2023: $1,071 · 2024: $2,093 · 2025: $2,151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,584 · Food and Beverage: $1,463 · Education: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,584.39 |
| Food and Beverage | $1,463.01 |
| Education | $266.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $25,037.01 | 2019-2025 | Da Vinci Surgical System |
| Covidien LP | $471.16 | 2019 | |
| Ethicon US, LLC | $367.88 | 2019-2022 | |
| Inspire Medical Systems, INC. | $103.85 | 2023 | Inspire |
| Medtronic, INC. | $97.40 | 2023-2024 | Signia |
| Avanos Medical | $27.03 | 2025 | On-Q Pump and Accessories |
| Otsuka America Pharmaceutical, INC. | $20.25 | 2019 | |
| Biocomposites INC | $13.67 | 2025 | Stimulan |
| Glaxosmithkline, LLC. | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Acosta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.